View of Emerging drug discovery paradigm in non small cell lung cancer: pharmacophore modeling, atom-based 3D- QSAR and virtual screening of novel EGFR inhibitors

Return to Article Details Emerging drug discovery paradigm in non small cell lung cancer: pharmacophore modeling, atom-based 3D- QSAR and virtual screening of novel EGFR inhibitors Download Download PDF